| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | PMS1 KIF13B BPTF ABCB7 KIF27 IPO8 ATRX MYO5B KIF14 MACF1 CHD9 KIF5A | 1.57e-06 | 614 | 71 | 12 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 3.46e-06 | 441 | 71 | 10 | GO:0016887 | |
| GeneOntologyMolecularFunction | microtubule binding | 1.34e-05 | 308 | 71 | 8 | GO:0008017 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 6.31e-05 | 118 | 71 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | PMS1 KIF13B ABCB7 KIF27 ATRX MYO5B KIF14 MACF1 CHD9 KIF5A DNM2 | 8.57e-05 | 775 | 71 | 11 | GO:0017111 |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.13e-04 | 70 | 71 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | KIF13B AP1AR MAP9 DCDC2 KIF27 MYO5B MICAL2 CEP57L1 KIF14 MACF1 KIF5A MRTFA DNM2 | 1.17e-04 | 1099 | 71 | 13 | GO:0008092 |
| GeneOntologyMolecularFunction | tubulin binding | 1.36e-04 | 428 | 71 | 8 | GO:0015631 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | PMS1 KIF13B ABCB7 KIF27 ATRX MYO5B KIF14 MACF1 CHD9 KIF5A DNM2 | 1.72e-04 | 839 | 71 | 11 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | PMS1 KIF13B ABCB7 KIF27 ATRX MYO5B KIF14 MACF1 CHD9 KIF5A DNM2 | 1.74e-04 | 840 | 71 | 11 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | PMS1 KIF13B ABCB7 KIF27 ATRX MYO5B KIF14 MACF1 CHD9 KIF5A DNM2 | 1.74e-04 | 840 | 71 | 11 | GO:0016818 |
| GeneOntologyMolecularFunction | kinesin binding | 9.90e-04 | 55 | 71 | 3 | GO:0019894 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.09e-03 | 127 | 71 | 4 | GO:0008094 | |
| GeneOntologyMolecularFunction | plus-end-directed microtubule motor activity | 1.64e-03 | 17 | 71 | 2 | GO:0008574 | |
| GeneOntologyMolecularFunction | GTPase binding | 1.76e-03 | 360 | 71 | 6 | GO:0051020 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 2.41e-03 | 262 | 71 | 5 | GO:0140097 | |
| GeneOntologyCellularComponent | kinesin complex | 2.31e-05 | 49 | 71 | 4 | GO:0005871 | |
| GeneOntologyCellularComponent | microtubule | 7.78e-05 | 533 | 71 | 9 | GO:0005874 | |
| GeneOntologyCellularComponent | supramolecular fiber | KIF13B MAP9 DCDC2 KIF27 MICAL2 CEP57L1 SCN8A KIF14 MACF1 MYOM2 KIF5A DNM2 | 5.71e-04 | 1179 | 71 | 12 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KIF13B MAP9 DCDC2 KIF27 MICAL2 CEP57L1 SCN8A KIF14 MACF1 MYOM2 KIF5A DNM2 | 6.06e-04 | 1187 | 71 | 12 | GO:0099081 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KIF13B MAP9 DCDC2 KIF27 MICAL2 CEP57L1 KIF14 MACF1 KIF5A DNM2 | 8.80e-04 | 899 | 71 | 10 | GO:0099513 |
| GeneOntologyCellularComponent | ISWI-type complex | 1.01e-03 | 14 | 71 | 2 | GO:0031010 | |
| HumanPheno | Attention deficit hyperactivity disorder | PMS1 DCDC2 ALKBH8 KMT5B NEXMIF SCN8A ZMYM2 KIF14 STIL HERC2 JMJD1C | 1.66e-05 | 413 | 31 | 11 | HP:0007018 |
| HumanPheno | Functional abnormality of the bladder | BPTF DCDC2 ATRX NEXMIF SCN4A TRPS1 ZMYM2 KIF14 MACF1 KIF5A STIL JMJD1C DNM2 | 1.68e-05 | 590 | 31 | 13 | HP:0000009 |
| HumanPheno | Abnormality of the bladder | BPTF DCDC2 ATRX NEXMIF SCN4A TRPS1 ZMYM2 KIF14 MACF1 KIF5A STIL JMJD1C DNM2 | 2.94e-05 | 621 | 31 | 13 | HP:0000014 |
| HumanPheno | Vesicoureteral reflux | 3.67e-05 | 221 | 31 | 8 | HP:0000076 | |
| HumanPheno | Hyperactivity | PMS1 DCDC2 ALKBH8 ATRX KMT5B NEXMIF SCN8A ZMYM2 KIF14 STIL HERC2 JMJD1C | 5.26e-05 | 558 | 31 | 12 | HP:0000752 |
| HumanPheno | Abnormal ureter physiology | 7.68e-05 | 245 | 31 | 8 | HP:0025634 | |
| HumanPheno | Abnormal thought pattern | DCDC2 ALKBH8 ATRX KMT5B NEXMIF SCN8A ZMYM2 MACF1 HERC2 USP48 | 8.56e-05 | 404 | 31 | 10 | HP:5200269 |
| HumanPheno | Abnormality of the lower urinary tract | BPTF DCDC2 ATRX NEXMIF SCN4A TRPS1 ZMYM2 KIF14 MACF1 KIF5A STIL KAT6B JMJD1C DNM2 EPG5 | 1.32e-04 | 937 | 31 | 15 | HP:0010936 |
| HumanPheno | Short attention span | PMS1 DCDC2 ALKBH8 KMT5B NEXMIF SCN8A ZMYM2 KIF14 STIL HERC2 JMJD1C | 1.35e-04 | 517 | 31 | 11 | HP:0000736 |
| HumanPheno | Reduced attention regulation | PMS1 DCDC2 ALKBH8 KMT5B NEXMIF SCN8A ZMYM2 KIF14 STIL HERC2 JMJD1C | 1.58e-04 | 526 | 31 | 11 | HP:5200044 |
| HumanPheno | Thin scalp hair | 1.82e-04 | 143 | 31 | 6 | HP:0002556 | |
| HumanPheno | Thin hair | 1.82e-04 | 143 | 31 | 6 | HP:0002237 | |
| HumanPheno | Sparse scalp hair | 1.82e-04 | 143 | 31 | 6 | HP:0002209 | |
| HumanPheno | Abnormality of upper lip vermillion | 2.73e-04 | 464 | 31 | 10 | HP:0011339 | |
| HumanPheno | Abnormality of the ureter | 3.17e-04 | 383 | 31 | 9 | HP:0000069 | |
| HumanPheno | Suicidal ideation | 3.33e-04 | 23 | 31 | 3 | HP:0031589 | |
| HumanPheno | Impairment in personality functioning | PMS1 BPTF DCDC2 ABCB7 ALKBH8 ATRX KMT5B NEXMIF SCN8A ZMYM2 KIF14 STIL HERC2 RIMS2 USP48 JMJD1C | 3.41e-04 | 1141 | 31 | 16 | HP:0031466 |
| HumanPheno | Abnormal eyelid morphology | BPTF RNF2 IPO8 ATRX KMT5B NEXMIF SCN4A TRPS1 SCN8A ZMYM2 KIF14 MACF1 LTV1 STIL HERC2 KAT6B JMJD1C EPG5 | 3.49e-04 | 1408 | 31 | 18 | HP:0000492 |
| HumanPheno | Abnormal nasal bridge morphology | BPTF RNF2 IPO8 ATRX KMT5B NEXMIF SCN4A TRPS1 ZMYM2 KIF14 MACF1 HERC2 KAT6B JMJD1C EPG5 | 3.91e-04 | 1029 | 31 | 15 | HP:0000422 |
| HumanPheno | Recurrent maladaptive behavior | PMS1 BPTF DCDC2 ALKBH8 ATRX KMT5B NEXMIF SCN4A SCN8A ZMYM2 KIF14 MACF1 STIL HERC2 RIMS2 USP48 JMJD1C | 4.27e-04 | 1293 | 31 | 17 | HP:5200241 |
| HumanPheno | Feeding difficulties | BPTF RNF2 IPO8 ATRX KMT5B NEXMIF SCN4A SCN8A ZMYM2 MACF1 KIF5A STIL HERC2 KAT6B JMJD1C EPG5 | 4.53e-04 | 1168 | 31 | 16 | HP:0011968 |
| HumanPheno | Disinhibition | PMS1 BPTF DCDC2 ALKBH8 ATRX KMT5B NEXMIF SCN8A ZMYM2 KIF14 STIL HERC2 JMJD1C | 4.57e-04 | 807 | 31 | 13 | HP:0000734 |
| HumanPheno | Inappropriate behavior | PMS1 BPTF DCDC2 ALKBH8 ATRX KMT5B NEXMIF SCN8A ZMYM2 KIF14 STIL HERC2 JMJD1C | 4.57e-04 | 807 | 31 | 13 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | PMS1 BPTF DCDC2 ALKBH8 ATRX KMT5B NEXMIF SCN8A ZMYM2 KIF14 STIL HERC2 JMJD1C | 4.57e-04 | 807 | 31 | 13 | HP:5200123 |
| HumanPheno | Social disinhibition | PMS1 BPTF DCDC2 ALKBH8 ATRX KMT5B NEXMIF SCN8A ZMYM2 KIF14 STIL HERC2 JMJD1C | 4.57e-04 | 807 | 31 | 13 | HP:5200029 |
| HumanPheno | Urinary incontinence | 5.27e-04 | 174 | 31 | 6 | HP:0000020 | |
| HumanPheno | Urinary or fecal incontinence | 5.27e-04 | 174 | 31 | 6 | HP:0007147 | |
| HumanPheno | Impaired continence | 5.43e-04 | 175 | 31 | 6 | HP:0031064 | |
| HumanPheno | Wide nasal bridge | 5.70e-04 | 508 | 31 | 10 | HP:0000431 | |
| Domain | Znf_FYVE_PHD | 1.71e-06 | 147 | 73 | 7 | IPR011011 | |
| Domain | Kinesin_motor_CS | 1.95e-05 | 41 | 73 | 4 | IPR019821 | |
| Domain | Kinesin-like_fam | 2.36e-05 | 43 | 73 | 4 | IPR027640 | |
| Domain | KINESIN_MOTOR_1 | 2.59e-05 | 44 | 73 | 4 | PS00411 | |
| Domain | - | 2.59e-05 | 44 | 73 | 4 | 3.40.850.10 | |
| Domain | Kinesin_motor_dom | 2.59e-05 | 44 | 73 | 4 | IPR001752 | |
| Domain | Kinesin | 2.59e-05 | 44 | 73 | 4 | PF00225 | |
| Domain | KINESIN_MOTOR_2 | 2.59e-05 | 44 | 73 | 4 | PS50067 | |
| Domain | KISc | 2.59e-05 | 44 | 73 | 4 | SM00129 | |
| Domain | DDT | 9.00e-05 | 4 | 73 | 2 | PF02791 | |
| Domain | DDT | 1.50e-04 | 5 | 73 | 2 | SM00571 | |
| Domain | WSD | 1.50e-04 | 5 | 73 | 2 | PF15613 | |
| Domain | WHIM1 | 1.50e-04 | 5 | 73 | 2 | PF15612 | |
| Domain | DDT_dom | 1.50e-04 | 5 | 73 | 2 | IPR018501 | |
| Domain | WHIM1_dom | 1.50e-04 | 5 | 73 | 2 | IPR028942 | |
| Domain | WHIM2_dom | 1.50e-04 | 5 | 73 | 2 | IPR028941 | |
| Domain | DDT | 2.24e-04 | 6 | 73 | 2 | PS50827 | |
| Domain | Kinesin_assoc | 2.24e-04 | 6 | 73 | 2 | PF16183 | |
| Domain | Kinesin_assoc | 2.24e-04 | 6 | 73 | 2 | IPR032405 | |
| Domain | Znf_FYVE-rel | 3.14e-04 | 34 | 73 | 3 | IPR017455 | |
| Domain | - | 3.59e-04 | 449 | 73 | 8 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 4.16e-04 | 459 | 73 | 8 | IPR013083 | |
| Domain | Znf_FYVE | 4.38e-04 | 38 | 73 | 3 | IPR000306 | |
| Domain | ZF_FYVE | 5.10e-04 | 40 | 73 | 3 | PS50178 | |
| Domain | ZF_PHD_2 | 5.23e-04 | 95 | 73 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 5.44e-04 | 96 | 73 | 4 | PS01359 | |
| Domain | Na_channel_asu | 6.64e-04 | 10 | 73 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 6.64e-04 | 10 | 73 | 2 | IPR010526 | |
| Domain | Na_trans_assoc | 6.64e-04 | 10 | 73 | 2 | PF06512 | |
| Domain | GATA_ZN_FINGER_1 | 1.75e-03 | 16 | 73 | 2 | PS00344 | |
| Domain | GATA_ZN_FINGER_2 | 1.75e-03 | 16 | 73 | 2 | PS50114 | |
| Domain | CH | 2.10e-03 | 65 | 73 | 3 | SM00033 | |
| Domain | CH | 2.60e-03 | 70 | 73 | 3 | PF00307 | |
| Domain | IQ | 2.71e-03 | 71 | 73 | 3 | PF00612 | |
| Domain | - | 2.71e-03 | 71 | 73 | 3 | 1.10.418.10 | |
| Domain | CH | 2.93e-03 | 73 | 73 | 3 | PS50021 | |
| Domain | PHD | 3.16e-03 | 75 | 73 | 3 | PF00628 | |
| Domain | CH-domain | 3.16e-03 | 75 | 73 | 3 | IPR001715 | |
| Domain | Znf_PHD-finger | 3.66e-03 | 79 | 73 | 3 | IPR019787 | |
| Domain | IQ | 3.93e-03 | 81 | 73 | 3 | SM00015 | |
| Domain | Bromodomain_CS | 4.61e-03 | 26 | 73 | 2 | IPR018359 | |
| Domain | AT_hook | 4.96e-03 | 27 | 73 | 2 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 4.96e-03 | 27 | 73 | 2 | IPR017956 | |
| Domain | PHD | 5.11e-03 | 89 | 73 | 3 | SM00249 | |
| Domain | TPR_1 | 5.28e-03 | 90 | 73 | 3 | PF00515 | |
| Domain | TPR_1 | 5.28e-03 | 90 | 73 | 3 | IPR001440 | |
| Domain | IQ_motif_EF-hand-BS | 5.28e-03 | 90 | 73 | 3 | IPR000048 | |
| Domain | FHA | 5.33e-03 | 28 | 73 | 2 | SM00240 | |
| Domain | Znf_PHD | 5.44e-03 | 91 | 73 | 3 | IPR001965 | |
| Domain | P-loop_NTPase | 5.65e-03 | 848 | 73 | 9 | IPR027417 | |
| Domain | FYVE | 5.71e-03 | 29 | 73 | 2 | PF01363 | |
| Domain | FYVE | 5.71e-03 | 29 | 73 | 2 | SM00064 | |
| Domain | IQ | 5.78e-03 | 93 | 73 | 3 | PS50096 | |
| Domain | FHA_DOMAIN | 6.51e-03 | 31 | 73 | 2 | PS50006 | |
| Domain | FHA | 6.51e-03 | 31 | 73 | 2 | PF00498 | |
| Domain | SNF2_N | 6.93e-03 | 32 | 73 | 2 | IPR000330 | |
| Domain | SNF2_N | 6.93e-03 | 32 | 73 | 2 | PF00176 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | PMS1 BPTF RNF2 ATRX BAZ2A ZMYM2 RRP15 CHD9 BOD1L1 HERC2 USP48 JMJD1C | 5.99e-09 | 608 | 74 | 12 | 36089195 |
| Pubmed | KIF13B BPTF AP1AR MAP9 GRPEL1 ILF3 RNF2 ATRX MYO5B SCN4A RRP15 MACF1 BOD1L1 PRPF6 MYOM2 KIF5A RIMS2 | 7.03e-09 | 1442 | 74 | 17 | 35575683 | |
| Pubmed | YEATS2 ATXN7L3 BPTF GRPEL1 RNF2 ATRX CNOT10 TRPS1 ZMYM2 RRP15 R3HDM2 LTV1 STK40 HERC2 CREB1 JMJD1C | 4.30e-08 | 1429 | 74 | 16 | 35140242 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 4.76e-08 | 341 | 74 | 9 | 32971831 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 2.20e-07 | 197 | 74 | 7 | 20811636 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | YEATS2 BPTF EIF2D ILF3 ATRX BAZ2A ZMYM2 RRP15 KAT6B MRTFA DNM2 | 7.22e-07 | 774 | 74 | 11 | 15302935 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PMS1 YEATS2 BPTF ILF3 ATRX BAZ2A ZMYM2 RRP15 BOD1L1 PRPF6 CREB1 JMJD1C | 7.79e-07 | 954 | 74 | 12 | 36373674 |
| Pubmed | 9.70e-07 | 83 | 74 | 5 | 28794006 | ||
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 1.58e-06 | 167 | 74 | 6 | 20362541 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 2.48e-06 | 283 | 74 | 7 | 30585729 | |
| Pubmed | Yeast two-hybrid screening identified WDR77 as a novel interacting partner of TSC22D2. | 2.63e-06 | 45 | 74 | 4 | 27337956 | |
| Pubmed | PMS1 GRPEL1 ABCB7 ILF3 IPO8 ATRX BAZ2A RRP15 MACF1 LTV1 PRPF6 HERC2 USP48 ARMC1 | 2.64e-06 | 1487 | 74 | 14 | 33957083 | |
| Pubmed | KIF13B MAP9 DCDC2 ABCB7 ALKBH8 ATRX CEP57L1 MACF1 BOD1L1 GPATCH2L MRTFA DNM2 | 2.93e-06 | 1084 | 74 | 12 | 11544199 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 4.07e-06 | 582 | 74 | 9 | 20467437 | |
| Pubmed | 8.15e-06 | 222 | 74 | 6 | 37071664 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 1.15e-05 | 358 | 74 | 7 | 32460013 | |
| Pubmed | Biological, clinical and population relevance of 95 loci for blood lipids. | 1.55e-05 | 146 | 74 | 5 | 20686565 | |
| Pubmed | 1.57e-05 | 689 | 74 | 9 | 36543142 | ||
| Pubmed | ATRX MICAL2 TRPS1 CEP57L1 ZMYM2 MACF1 CHD9 SPARCL1 ANKRD36 KIF5A HERC2 DNM2 | 1.62e-05 | 1285 | 74 | 12 | 35914814 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | YEATS2 ATXN7L3 BPTF ILF3 RNF2 ATRX BAZ2A ZMYM2 RRP15 PRPF6 CREB1 JMJD1C | 1.74e-05 | 1294 | 74 | 12 | 30804502 |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 1.77e-05 | 150 | 74 | 5 | 28242625 | |
| Pubmed | 1.95e-05 | 153 | 74 | 5 | 10718198 | ||
| Pubmed | Identification and classification of 16 new kinesin superfamily (KIF) proteins in mouse genome. | 2.06e-05 | 25 | 74 | 3 | 9275178 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | KIF13B CLGN RNF2 IPO8 LRCH2 ATRX MYO5B CNOT10 LTV1 PRPF6 FGD6 DNM2 | 2.13e-05 | 1321 | 74 | 12 | 27173435 |
| Pubmed | 2.20e-05 | 157 | 74 | 5 | 30186101 | ||
| Pubmed | 2.62e-05 | 407 | 74 | 7 | 12693553 | ||
| Pubmed | Redox modification of nuclear actin by MICAL-2 regulates SRF signaling. | 2.67e-05 | 4 | 74 | 2 | 24440334 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 2.79e-05 | 411 | 74 | 7 | 35182466 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 2.82e-05 | 934 | 74 | 10 | 33916271 | |
| Pubmed | 4.45e-05 | 5 | 74 | 2 | 25348260 | ||
| Pubmed | 4.45e-05 | 5 | 74 | 2 | 18187418 | ||
| Pubmed | NSD3-Short Is an Adaptor Protein that Couples BRD4 to the CHD8 Chromatin Remodeler. | 4.45e-05 | 5 | 74 | 2 | 26626481 | |
| Pubmed | 4.45e-05 | 5 | 74 | 2 | 17724025 | ||
| Pubmed | A molecular network for the transport of the TI-VAMP/VAMP7 vesicles from cell center to periphery. | 4.45e-05 | 5 | 74 | 2 | 22705394 | |
| Pubmed | 4.58e-05 | 183 | 74 | 5 | 36129980 | ||
| Pubmed | 5.63e-05 | 1014 | 74 | 10 | 32416067 | ||
| Pubmed | Piccolo, a presynaptic zinc finger protein structurally related to bassoon. | 6.66e-05 | 6 | 74 | 2 | 10707984 | |
| Pubmed | 7.39e-05 | 104 | 74 | 4 | 9205841 | ||
| Pubmed | Loss of Rearranged L-Myc Fusion (RLF) results in defects in heart development in the mouse. | 7.39e-05 | 38 | 74 | 3 | 27930960 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 7.49e-05 | 203 | 74 | 5 | 22083510 | |
| Pubmed | 7.50e-05 | 481 | 74 | 7 | 28190767 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 7.76e-05 | 332 | 74 | 6 | 32786267 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 8.48e-05 | 857 | 74 | 9 | 25609649 | |
| Pubmed | 1.13e-04 | 1103 | 74 | 10 | 34189442 | ||
| Pubmed | 1.13e-04 | 116 | 74 | 4 | 21282530 | ||
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 1.42e-04 | 533 | 74 | 7 | 30554943 | |
| Pubmed | 1.46e-04 | 124 | 74 | 4 | 20850016 | ||
| Pubmed | 1.51e-04 | 125 | 74 | 4 | 29467281 | ||
| Pubmed | 1.59e-04 | 9 | 74 | 2 | 16382098 | ||
| Pubmed | 1.59e-04 | 9 | 74 | 2 | 15746173 | ||
| Pubmed | 1.70e-04 | 549 | 74 | 7 | 38280479 | ||
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | 1.75e-04 | 552 | 74 | 7 | 10737800 | |
| Pubmed | Identification of 14-3-3epsilon substrates from embryonic murine brain. | 1.86e-04 | 132 | 74 | 4 | 16944949 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 1.97e-04 | 394 | 74 | 6 | 27248496 | |
| Pubmed | 1.99e-04 | 10 | 74 | 2 | 36635505 | ||
| Pubmed | 2.01e-04 | 754 | 74 | 8 | 35906200 | ||
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 2.02e-04 | 135 | 74 | 4 | 31077711 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ILF3 RNF2 KIF27 IPO8 ATRX KIF14 RRP15 BOD1L1 LTV1 FGD5 PRPF6 | 2.05e-04 | 1425 | 74 | 11 | 30948266 |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 2.45e-04 | 583 | 74 | 7 | 29844126 | |
| Pubmed | 2.49e-04 | 57 | 74 | 3 | 29089450 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 2.58e-04 | 588 | 74 | 7 | 38580884 | |
| Pubmed | IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA. | 2.62e-04 | 58 | 74 | 3 | 21642987 | |
| Pubmed | 2.66e-04 | 591 | 74 | 7 | 15231748 | ||
| Pubmed | 2.70e-04 | 418 | 74 | 6 | 34709266 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 2.73e-04 | 146 | 74 | 4 | 23892456 | |
| Pubmed | 2.73e-04 | 268 | 74 | 5 | 33640491 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | 2.79e-04 | 1005 | 74 | 9 | 19615732 | |
| Pubmed | 2.90e-04 | 60 | 74 | 3 | 26472337 | ||
| Pubmed | 2.92e-04 | 272 | 74 | 5 | 31010829 | ||
| Pubmed | 3.10e-04 | 151 | 74 | 4 | 17043677 | ||
| Pubmed | ATXN7L3 RNF2 ATRX BAZ2A CNOT10 TRPS1 ZMYM2 KIF14 RRP15 MACF1 HERC2 | 3.13e-04 | 1497 | 74 | 11 | 31527615 | |
| Pubmed | The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer. | 4.00e-04 | 14 | 74 | 2 | 27626314 | |
| Pubmed | A germline-specific class of small RNAs binds mammalian Piwi proteins. | 4.00e-04 | 450 | 74 | 6 | 16751776 | |
| Pubmed | 4.20e-04 | 638 | 74 | 7 | 31182584 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 4.58e-04 | 853 | 74 | 8 | 28718761 | |
| Pubmed | Viral protein engagement of GBF1 induces host cell vulnerability through synthetic lethality. | 4.76e-04 | 71 | 74 | 3 | 36305789 | |
| Pubmed | 4.83e-04 | 653 | 74 | 7 | 22586326 | ||
| Pubmed | 4.93e-04 | 305 | 74 | 5 | 21244100 | ||
| Pubmed | 5.14e-04 | 472 | 74 | 6 | 38943005 | ||
| Pubmed | 5.26e-04 | 16 | 74 | 2 | 12781685 | ||
| Pubmed | 5.65e-04 | 177 | 74 | 4 | 26206133 | ||
| Pubmed | 5.81e-04 | 76 | 74 | 3 | 10574461 | ||
| Pubmed | 5.95e-04 | 1116 | 74 | 9 | 31753913 | ||
| Pubmed | Evidence of Xist RNA-independent initiation of mouse imprinted X-chromosome inactivation. | 5.95e-04 | 17 | 74 | 2 | 19571810 | |
| Pubmed | The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma. | 5.95e-04 | 17 | 74 | 2 | 23502783 | |
| Pubmed | A global genomic transcriptional code associated with CNS-expressed genes. | 5.96e-04 | 318 | 74 | 5 | 16919269 | |
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | 6.21e-04 | 321 | 74 | 5 | 32098917 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 6.54e-04 | 184 | 74 | 4 | 32908313 | |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | 6.60e-04 | 495 | 74 | 6 | 27705803 | |
| Pubmed | 6.66e-04 | 326 | 74 | 5 | 17015433 | ||
| Pubmed | 6.74e-04 | 497 | 74 | 6 | 23414517 | ||
| Pubmed | 7.39e-04 | 506 | 74 | 6 | 30890647 | ||
| Pubmed | 7.50e-04 | 1153 | 74 | 9 | 29845934 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 7.59e-04 | 1155 | 74 | 9 | 20360068 | |
| Pubmed | The sperm-associated antigen 6 interactome and its role in spermatogenesis. | 8.75e-04 | 199 | 74 | 4 | 31146259 | |
| Pubmed | 9.14e-04 | 21 | 74 | 2 | 26468281 | ||
| Pubmed | A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome. | 9.77e-04 | 205 | 74 | 4 | 12040188 | |
| Pubmed | ATRX proximal protein associations boast roles beyond histone deposition. | 9.82e-04 | 91 | 74 | 3 | 34780483 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 1.00e-03 | 357 | 74 | 5 | 37059091 | |
| Pubmed | 1.01e-03 | 963 | 74 | 8 | 28671696 | ||
| Interaction | MAD2L1 interactions | 3.96e-06 | 252 | 74 | 8 | int:MAD2L1 | |
| Interaction | H2AZ1 interactions | 8.49e-06 | 371 | 74 | 9 | int:H2AZ1 | |
| Interaction | H3C3 interactions | 1.28e-05 | 495 | 74 | 10 | int:H3C3 | |
| Interaction | H3-3A interactions | PMS1 BPTF RNF2 ATRX BAZ2A ZMYM2 RRP15 CHD9 BOD1L1 HERC2 USP48 JMJD1C | 1.68e-05 | 749 | 74 | 12 | int:H3-3A |
| Interaction | HSPA4L interactions | 3.69e-05 | 250 | 74 | 7 | int:HSPA4L | |
| Interaction | YWHAH interactions | KIF13B GRPEL1 ILF3 LRCH2 KIF14 MACF1 R3HDM2 BOD1L1 PRPF6 KIF5A STIL RIMS2 USP48 FGD6 | 4.13e-05 | 1102 | 74 | 14 | int:YWHAH |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 6.57e-06 | 46 | 48 | 4 | 622 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 2.46e-04 | 9 | 48 | 2 | 1203 | |
| GeneFamily | PHD finger proteins | 1.75e-03 | 90 | 48 | 3 | 88 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 3.06e-03 | 31 | 48 | 2 | 81 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PMS1 BPTF RNF2 ATRX MICAL2 ZMYM2 KIF14 MACF1 CHD9 R3HDM2 STIL KAT6B CREB1 MRTFA | 1.04e-07 | 856 | 74 | 14 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 7.45e-07 | 466 | 74 | 10 | M13522 | |
| Coexpression | GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_DN | 7.13e-06 | 164 | 74 | 6 | M2972 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.21e-05 | 180 | 74 | 6 | M8239 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 2.24e-05 | 300 | 74 | 7 | M8702 | |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 5.73e-05 | 145 | 74 | 5 | M1810 | |
| Coexpression | BILD_CTNNB1_ONCOGENIC_SIGNATURE | 7.49e-05 | 79 | 74 | 4 | M7102 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | PMS1 BPTF ABCB7 RNF2 IPO8 LRCH2 ATRX TRPS1 SCN8A ZMYM2 MACF1 CHD9 BOD1L1 C1GALT1 PRPF6 STIL AKAP7 | 9.07e-07 | 1257 | 73 | 17 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | PMS1 BPTF RNF2 ATRX MICAL2 CEP57L1 MACF1 CHD9 BOD1L1 PRPF6 RIMS2 | 5.62e-06 | 595 | 73 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | PMS1 BPTF ABCB7 RNF2 IPO8 LRCH2 ATRX TRPS1 SCN8A ZMYM2 MACF1 CHD9 BOD1L1 C1GALT1 PRPF6 STIL AKAP7 | 6.83e-06 | 1459 | 73 | 17 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | PMS1 ABCB7 KIF27 CCDC73 BAZ2A MACROD2 KIF14 CCDC25 LTV1 RIMS2 FGD6 REV1 | 2.14e-05 | 820 | 73 | 12 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | 5.61e-05 | 629 | 73 | 10 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | IPO8 LRCH2 ATRX NEXMIF TRPS1 SCN8A ZMYM2 KIF14 MACF1 CHD9 CCDC25 BOD1L1 STIL | 5.88e-05 | 1060 | 73 | 13 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | YEATS2 AP1AR LRCH2 MYO5B NEXMIF NYNRIN TRPS1 SPARCL1 KAT6B AKAP7 PLIN2 | 7.06e-05 | 783 | 73 | 11 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.32e-04 | 564 | 73 | 9 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-08 | 176 | 74 | 7 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-07 | 192 | 74 | 6 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.03e-06 | 200 | 74 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.15e-05 | 177 | 74 | 5 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.15e-05 | 177 | 74 | 5 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 1.15e-05 | 177 | 74 | 5 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.15e-05 | 177 | 74 | 5 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.15e-05 | 177 | 74 | 5 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 1.35e-05 | 183 | 74 | 5 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 185 | 74 | 5 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-05 | 187 | 74 | 5 | 7b2cd0c618ed081223343f3bec2244c8723c9a31 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.58e-05 | 189 | 74 | 5 | b13f315f617840eb5143a4e8a33a657c20365c21 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 1.70e-05 | 192 | 74 | 5 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.75e-05 | 193 | 74 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.84e-05 | 195 | 74 | 5 | 481989d2e5bd2582da3d86b0155c4d6615317067 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.84e-05 | 195 | 74 | 5 | 6108a27523d1b93a7fbe35cb95704a5ad9071e3c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.88e-05 | 196 | 74 | 5 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.93e-05 | 197 | 74 | 5 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.07e-05 | 200 | 74 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 2.07e-05 | 200 | 74 | 5 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 2.07e-05 | 200 | 74 | 5 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Control-B_activate-7|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.55e-05 | 130 | 74 | 4 | d3343c19d61928f18e7d707eda5dec6e0fd2a9a2 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_3|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.11e-04 | 149 | 74 | 4 | 651494e84be03dc7b061ebdfa91756a1c507b9b4 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.36e-04 | 157 | 74 | 4 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.72e-04 | 167 | 74 | 4 | a54b8e03987a7b067173121902e1811a3d003692 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.76e-04 | 168 | 74 | 4 | c3d2d573f21350a4a674faff30b06ff644d00ac3 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.88e-04 | 171 | 74 | 4 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.88e-04 | 171 | 74 | 4 | 4f2a83d8091f1fd29542d2e5add57fd482e921b5 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-04 | 172 | 74 | 4 | 073a503dc922e3e3ac3528e249b0f8b74402110b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-04 | 175 | 74 | 4 | 65571d775d26a40e979dbf290a8e4320c0d9fb3f | |
| ToppCell | droplet-Lung-18m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.10e-04 | 176 | 74 | 4 | b17317ac41d3215db55a38cbd3366c0947f7a2a3 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 177 | 74 | 4 | c6812679aa6522d03bd29144e71c5fae6a92325e | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 177 | 74 | 4 | ff97398d2adb83063b7c53a264bfae86ea7ea304 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-04 | 180 | 74 | 4 | f6a2208960d0df1500c974cc44c3c054cd7475a9 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-04 | 182 | 74 | 4 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-04 | 182 | 74 | 4 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-04 | 182 | 74 | 4 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | COVID-19_Severe-Hematopoietic_SC-HSPC|COVID-19_Severe / Disease group, lineage and cell class | 2.44e-04 | 183 | 74 | 4 | 4146b1c0e5f76d25226745abfa28f77127a444fc | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5|TCGA-Liver / Sample_Type by Project: Shred V9 | 2.44e-04 | 183 | 74 | 4 | f604a8b62c7088fad8365dbf8d910fc980bd3ba8 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 2.44e-04 | 183 | 74 | 4 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | COVID-19_Severe-Hematopoietic_SC|COVID-19_Severe / Disease group, lineage and cell class | 2.44e-04 | 183 | 74 | 4 | 92aab7ce65aca17988bc2add4ff9fb8384e2c21b | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-04 | 184 | 74 | 4 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | wk_08-11-Epithelial-PNS-PCP4+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.49e-04 | 184 | 74 | 4 | eac2a9089913f33a961ba11519b53645790f2056 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 2.54e-04 | 185 | 74 | 4 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-04 | 185 | 74 | 4 | cdd75abdaa1ecedfd2e636203b83a6ac1782f0c3 | |
| ToppCell | COVID-19_Convalescent-PLT_4|World / Disease Group and Platelet Clusters | 2.60e-04 | 186 | 74 | 4 | 5954a1e3ffafb33f2a9bc87af3343f304fda4c92 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.60e-04 | 186 | 74 | 4 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-04 | 186 | 74 | 4 | a1ab273b01971d6a892912560d387685dd657179 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-04 | 187 | 74 | 4 | ef3c85c01bc3da408ae288b6e3096ad888a12e63 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.65e-04 | 187 | 74 | 4 | db2974e2e87ac9f1c2407a371d5ed89af09fc9b7 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.70e-04 | 188 | 74 | 4 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.70e-04 | 188 | 74 | 4 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.70e-04 | 188 | 74 | 4 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.70e-04 | 188 | 74 | 4 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | COVID_vent-Myeloid-Monocytic-SC_&_Eosinophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.76e-04 | 189 | 74 | 4 | 2157a2d40613f7d5ce2e7dbd266df441e449cdaf | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-04 | 189 | 74 | 4 | 3d838da870623a6a278ddc8e6cedca85d9877e50 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.81e-04 | 190 | 74 | 4 | 5c012935ea5e35a2d0d08ea7dc04ffbe3c2a10ac | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-04 | 191 | 74 | 4 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.87e-04 | 191 | 74 | 4 | 39220f4a345e328f7fa4fd462a0abeea821b3e02 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-04 | 191 | 74 | 4 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-04 | 191 | 74 | 4 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.93e-04 | 192 | 74 | 4 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-04 | 193 | 74 | 4 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-04 | 193 | 74 | 4 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-04 | 193 | 74 | 4 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-04 | 193 | 74 | 4 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.05e-04 | 194 | 74 | 4 | 6cf9d59aec8dd18fa2fc1652ddd0f5ef1f24bcb6 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 3.05e-04 | 194 | 74 | 4 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.05e-04 | 194 | 74 | 4 | c197e4acbff42a9f0410b6801c2bfcf6160aefc1 | |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.05e-04 | 194 | 74 | 4 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.05e-04 | 194 | 74 | 4 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.05e-04 | 194 | 74 | 4 | d852aebf7a763b9a776c4570711f0c759f591910 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.05e-04 | 194 | 74 | 4 | c47fc3f716ab091a39c20d7639ac783029589ee5 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.11e-04 | 195 | 74 | 4 | f08e41706680881ebd0afcd08a02f8ac0089f04e | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.11e-04 | 195 | 74 | 4 | 0a72b8446399807ace5b6c72f865bb40dbd9e92d | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.11e-04 | 195 | 74 | 4 | 62d369a8af2b76a2553bc8ff9cb89a133b060123 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 195 | 74 | 4 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.11e-04 | 195 | 74 | 4 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 3.11e-04 | 195 | 74 | 4 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 195 | 74 | 4 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 3.17e-04 | 196 | 74 | 4 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.17e-04 | 196 | 74 | 4 | 0a34a0009f479384f1994c6f977f942699a132c8 | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.17e-04 | 196 | 74 | 4 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.23e-04 | 197 | 74 | 4 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.23e-04 | 197 | 74 | 4 | 6852a8ec1397811bbdd1fc625c52ed4fa75a931e | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.23e-04 | 197 | 74 | 4 | 2f91b3870a7058168093a143110954c07588cfe9 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.29e-04 | 198 | 74 | 4 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.29e-04 | 198 | 74 | 4 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | mild_COVID-19_(asymptomatic)-NK|World / disease group, cell group and cell class (v2) | 3.29e-04 | 198 | 74 | 4 | 7a0aac52d785037455e068e1b25de4b2bf0fff79 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.29e-04 | 198 | 74 | 4 | 0e918e9db9b884f5328d438e90efe065e27266ee | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.29e-04 | 198 | 74 | 4 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.29e-04 | 198 | 74 | 4 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.29e-04 | 198 | 74 | 4 | ce92d5fbc2eac27fb246b044fb1914ab92506275 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.29e-04 | 198 | 74 | 4 | fed823d6e684d113bcc9ff3cd1803bb001aa02fa | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 3.29e-04 | 198 | 74 | 4 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.29e-04 | 198 | 74 | 4 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.29e-04 | 198 | 74 | 4 | 1ef3a6bd681c223eed58300348adfef89df5563c | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 3.29e-04 | 198 | 74 | 4 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.35e-04 | 199 | 74 | 4 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 3.35e-04 | 199 | 74 | 4 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| Computational | Neighborhood of UBE2N | 3.53e-05 | 154 | 44 | 6 | GCM_UBE2N | |
| Computational | Neighborhood of MLL | 6.99e-05 | 174 | 44 | 6 | GCM_MLL | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 6.39e-05 | 276 | 73 | 6 | EFO_0004612, EFO_0020943 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 1.69e-04 | 111 | 73 | 4 | EFO_0004530, EFO_0008595 | |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 2.35e-04 | 121 | 73 | 4 | EFO_0004612, EFO_0005271 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 2.68e-04 | 10 | 73 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 2.68e-04 | 10 | 73 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 3.46e-04 | 243 | 73 | 5 | EFO_0004612, EFO_0020944 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 3.92e-04 | 12 | 73 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement | 4.71e-04 | 260 | 73 | 5 | EFO_0008317 | |
| Disease | actinic keratosis | 5.39e-04 | 14 | 73 | 2 | EFO_0002496 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 5.59e-04 | 152 | 73 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Tremor, Rubral | 7.08e-04 | 16 | 73 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 7.08e-04 | 16 | 73 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 7.08e-04 | 16 | 73 | 2 | C0278161 | |
| Disease | Abnormal coordination | 7.08e-04 | 16 | 73 | 2 | C0520966 | |
| Disease | Ataxia, Truncal | 7.08e-04 | 16 | 73 | 2 | C0427190 | |
| Disease | Ataxia, Sensory | 7.08e-04 | 16 | 73 | 2 | C0240991 | |
| Disease | forced expiratory volume | 7.33e-04 | 789 | 73 | 8 | EFO_0004314 | |
| Disease | fatty acid measurement | 7.43e-04 | 436 | 73 | 6 | EFO_0005110 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 7.77e-04 | 166 | 73 | 4 | EFO_0004530, EFO_0004611 | |
| Disease | Intellectual Disability | 8.45e-04 | 447 | 73 | 6 | C3714756 | |
| Disease | Epilepsy, Cryptogenic | 1.12e-03 | 82 | 73 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 1.12e-03 | 82 | 73 | 3 | C0751111 | |
| Disease | Aura | 1.12e-03 | 82 | 73 | 3 | C0236018 | |
| Disease | testosterone measurement | KIF27 CCDC73 NYNRIN TRPS1 MACF1 R3HDM2 USP48 CREB1 JMJD1C PLIN2 | 1.14e-03 | 1275 | 73 | 10 | EFO_0004908 |
| Disease | Ischemic stroke | 1.26e-03 | 324 | 73 | 5 | HP_0002140 | |
| Disease | Autosomal Recessive Primary Microcephaly | 1.35e-03 | 22 | 73 | 2 | C3711387 | |
| Disease | Neurodevelopmental Disorders | 1.61e-03 | 93 | 73 | 3 | C1535926 | |
| Disease | Ataxia | 1.75e-03 | 25 | 73 | 2 | C0004134 | |
| Disease | HVA measurement | 1.89e-03 | 26 | 73 | 2 | EFO_0005131 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 2.01e-03 | 215 | 73 | 4 | EFO_0008317, EFO_0008591 | |
| Disease | necrotizing enterocolitis | 2.04e-03 | 27 | 73 | 2 | EFO_0003928 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 2.19e-03 | 220 | 73 | 4 | EFO_0004529, EFO_0008317 | |
| Disease | S-6-hydroxywarfarin measurement | 2.20e-03 | 368 | 73 | 5 | EFO_0803326 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 2.34e-03 | 224 | 73 | 4 | EFO_0004530, EFO_0008317 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 2.34e-03 | 224 | 73 | 4 | EFO_0004574, EFO_0008317 | |
| Disease | free androgen index | 2.36e-03 | 374 | 73 | 5 | EFO_0007005 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EKSNEEGQADVQMNG | 511 | Q5RHP9 | |
| SQLQDDASGQNESEM | 66 | Q9HCE0 | |
| NQDSTDSKTLQEQMD | 251 | P41214 | |
| NRNSQGKKEEMNSDT | 521 | Q96BT7 | |
| VKTEAADQNGNDNEN | 331 | Q9P0M2 | |
| LNNGSDAEQEEMETQ | 386 | Q9UIF9 | |
| SVKTEAADQNGNDNE | 86 | O43687 | |
| QSSNMADGDSFNEMN | 111 | Q9NVT9 | |
| GIDKTENGNMFEDQN | 446 | A6QL64 | |
| ENGNMFEDQNVDKEG | 451 | A6QL64 | |
| ENDFVSAEMDDNGNS | 261 | Q63HQ0 | |
| KTDENEQDQSASVDM | 351 | Q96K78 | |
| SDAAKGADQNEMDIS | 1101 | Q12830 | |
| ANSNNMNKSESDQED | 121 | Q14CW9 | |
| DASMDRDDNQTGQNG | 261 | Q9Y2K5 | |
| RNNMNDDSSNLKEGS | 1221 | Q8WYB5 | |
| NGNNKAASVQEEFMD | 1401 | Q15058 | |
| QANKATGEEEGMDIQ | 166 | Q96GA3 | |
| DTSADENSVNKKMND | 61 | Q49MG5 | |
| SGQNLEEDMGQSEQK | 36 | Q9HAV7 | |
| DNVEEDMNASAQGAS | 1826 | O95714 | |
| SSSKTNDQENDGMNS | 726 | Q4FZB7 | |
| NDQENDGMNSSKISI | 731 | Q4FZB7 | |
| EDKNTNKMENSGNSV | 1561 | Q15652 | |
| MLGNENKTETDDNQF | 1316 | Q86VH2 | |
| SMNSQASLDNTDDEQ | 401 | Q5SWX8 | |
| KVTDRANDSMEQGEN | 1076 | Q6ZNL6 | |
| QAENEDGAQENTFSM | 631 | P50570 | |
| KVENMSSNQDGNDSD | 191 | Q86WR0 | |
| NMGNDTNEEQEKAVT | 2906 | Q9UPN3 | |
| DGSGSIDQNDFNQMK | 156 | Q13349 | |
| MGEESQQQQEQKGDA | 106 | Q9UQ26 | |
| EAEAGAAIMNANENN | 1916 | Q8NFC6 | |
| ANENNVDSMSGTEKG | 1926 | Q8NFC6 | |
| DASNENSENDITMQS | 106 | P46100 | |
| TQDETQDSFQMNNGT | 2226 | Q3L8U1 | |
| DSDMGFHESQQNQKS | 66 | Q96BT1 | |
| NNENSEMSTEKSENT | 401 | Q6ZRK6 | |
| EQEKGSSEQAESDNM | 51 | Q12906 | |
| QMQNTGESEASGNKE | 291 | O14879 | |
| QSGDAAVTEAENQQM | 11 | P16220 | |
| ETDEQKQGSDENMSE | 206 | Q9NWQ4 | |
| QKANMDNGNATDIND | 991 | Q12840 | |
| GQMNFNADSSQHKDE | 61 | Q9NS00 | |
| QNSKMSEASGIQQED | 396 | Q8IYX8 | |
| QNDMHNDESGKNTDD | 391 | P54277 | |
| ANKDAEQKEDFSGMN | 356 | Q9UHG0 | |
| GESNQMNLDTASEKQ | 276 | Q99496 | |
| NENDEQDSDNANMST | 576 | Q5VUJ6 | |
| MGENEDEKQAQAGQV | 1 | O94851 | |
| RVGSNNQDGMDSAQE | 286 | Q9P2P1 | |
| NQDGMDSAQEEGTVQ | 291 | Q9P2P1 | |
| TAQAMQSNNGRGEDE | 911 | O15397 | |
| EMKGKGQNDEENTQE | 46 | A1Z1Q3 | |
| SMKNENSSEQLDVDG | 561 | Q9NQT8 | |
| IDDQMSNADSSQEAK | 351 | Q8N2I9 | |
| AASDEDGEMNNLQIA | 811 | P35499 | |
| VGDQMKKNQAADDDD | 56 | O94906 | |
| NGVKENDSEDQDVAM | 21 | Q5QGS0 | |
| PKQQENGSSSQQMDD | 736 | Q969V6 | |
| EMNKADNDAGNAAID | 321 | O75027 | |
| EESNQSNKSGSEDEM | 571 | O14967 | |
| KQNNEDDYLSDGMNS | 641 | Q16280 | |
| QDQGSDKGENEAMES | 611 | Q9H9A5 | |
| SENEGMASNQGKMEN | 6 | Q96EI5 | |
| QMSENTDQSDAAELN | 41 | Q9UHF7 | |
| NAAGEDQEPDSQMKQ | 801 | Q15468 | |
| VKVNGMNSWNEEDEN | 181 | Q9UBZ9 | |
| NSNAEMEEENASNVN | 271 | Q14515 | |
| GNKSELNMESNSDAQ | 381 | Q6ZV73 | |
| AATDDDGEMNNLQIS | 986 | Q9UQD0 | |
| KENENDGESSVGTNM | 76 | Q9Y3B9 | |
| MAAQKDQQKDAEAEG | 1 | Q9UI14 | |
| DEEDMETNQGQEKNS | 121 | Q9UBW7 | |
| ESQNAQDQGAEMDKS | 411 | Q99541 | |
| QDQGAEMDKSSQETQ | 416 | Q99541 | |
| DEQDGDAEQSNGKMN | 611 | Q86UV5 | |
| HNDFLSDKDNNSNMD | 146 | Q9ULM3 | |
| DEGFMTQNTAKQNEH | 1566 | Q9ULV0 | |
| AVNAVGMSENSQESD | 686 | P54296 |